Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CD30: expression and function in health and disease

R Horie1, T Watanabe

  • 1The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo, 108-3639, Japan.

Seminars in Immunology
|November 25, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Superconductivity in 5d transition metal Laves phase SrIr<sub>2</sub>.

Journal of physics. Condensed matter : an Institute of Physics journal·2020
Same author

Inhibition of Bach1 ameliorates indomethacin-induced intestinal injury in mice.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2010
Same author

Decreased expression of CXXC4 promotes a malignant phenotype in renal cell carcinoma by activating Wnt signaling.

Oncogene·2008
Same author

DHMEQ, a new NF-kappaB inhibitor, induces apoptosis and enhances fludarabine effects on chronic lymphocytic leukemia cells.

Leukemia·2006
Same author

Homogenous simultaneous detection of HCV RNA and internal control by two-color fluorescence real-time monitoring of isothermal sequence amplification with INAF probes.

Nucleic acids symposium series·2003
Same author

Primary gastric T-cell lymphoma not associated with human T-lymphotropic virus type I: a case report and review of the literature.

Annals of hematology·2003

CD30, a tumor necrosis factor receptor superfamily member, is expressed on lymphocytes and lymphoid neoplasms. Its ligand (CD30L) is found on various immune cells, suggesting a role in co-stimulatory immune signals.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • CD30 is a marker for Hodgkin's lymphoma cells.
  • CD30 and CD30L belong to the TNF receptor and TNF superfamilies.
  • CD30 is expressed on specific lymphocytes and lymphoid neoplasms.

Purpose of the Study:

  • To characterize CD30 and CD30L.
  • To understand the expression patterns of CD30 and CD30L.
  • To elucidate the biological functions and signal transduction of CD30.

Main Methods:

  • Cloning and characterization of CD30 and CD30L cDNAs.
  • Analysis of CD30 and CD30L expression in various cell types.
  • Investigation of CD30 signal transduction pathways.

Related Experiment Videos

Main Results:

  • CD30 and CD30L were identified as members of the TNFR and TNF superfamilies.
  • Expression of CD30 is largely restricted to specific immune cells and lymphoid neoplasms.
  • CD30 signal transduction involves TNFR-associated factors (TRAFs).

Conclusions:

  • CD30 plays a role in immune regulation, particularly co-stimulation.
  • The diverse biological functions of CD30 are mediated through TRAF proteins.
  • Further research is needed to fully understand CD30 signaling mechanisms.